A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein–Protein Interaction Implicated in Breast Cancer
ChemBioChem · 2025
DOI: 10.1002/cbic.202500343 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von James Luccarelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK. Hauptthemen laut MEDLINE: GRB2 Adaptor Protein, Peptidomimetics, Peptides, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oxford, Cancer Research UK, Wessex Medical Research.
Abstract (Originalsprache)
Given the essential role of protein–protein interactions (PPIs) in cellular signaling pathways, their selective modulation is of great therapeutic interest. Mimicry of secondary structural protein elements has emerged as a promising strategy, with various scaffolds reproducing recognition surfaces of α –helical and β –strand/sheet proteins. A critical PPI, controlling cell growth and proliferation in breast and other cancers, occurs between growth factor receptor‐bound protein 2 (Grb2) and a polyproline II (PPII) helix embedded in Gab2. Herein, the first example of a general approach for nonpeptidic mimicry of extended PPII helices is presented and it is demonstrated that the scaffold may be functionalized to recapitulate the binding characteristics of crucial hydrophobic and cationic Gab2 hot‐spot side‐chains. The rationally designed peptidomimetic binds Grb2 at the same position as Gab2 (protein‐observed nuclear magnetic resonance (NMR)) with affinities comparable to the native peptide sequence (surface plasmon resonance (SPR)). With the addition of a new PPII minimalist scaffold, these studies further validate the use of diverse secondary structure peptidomimetics in disrupting therapeutically relevant PPIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
- Biological Systems Architecture Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
- Department of Chemistry, New York University, 100 Washington Square East, New York, NY, 10003, USA.
- Institute for Molecular Medicine, Martin-Luther University, Halle-Wittenberg, 06120, Halle Saale, Germany.
- School of Chemistry and The Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
ORCID-Profile: Sam Thompson
Förderung
- University of Oxford
- Cancer Research UK
- Wessex Medical Research
- Oxford Cancer Research Centre Development Fund
- NIMH NIH HHS
- Rosetrees Trust
- DFG
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Luccarelli, J., Simister, P. C., Hamilton, A. D., Feller, S. M., & Thompson, S. (2025). A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein–Protein Interaction Implicated in Breast Cancer. ChemBioChem. https://doi.org/10.1002/cbic.202500343
Vancouver
Luccarelli J, Simister PC, Hamilton AD, Feller SM, Thompson S. A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein–Protein Interaction Implicated in Breast Cancer. ChemBioChem. 2025. doi:10.1002/cbic.202500343
BibTeX
@article{Luccarelli2025,
author = {Luccarelli, James and Simister, Philip C and Hamilton, Andrew D and Feller, Stephan M and Thompson, Sam},
title = {A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein–Protein Interaction Implicated in Breast Cancer},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500343}
}
EUVIMED